1. Home
  2. ELA vs TLSA Comparison

ELA vs TLSA Comparison

Compare ELA & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELA
  • TLSA
  • Stock Information
  • Founded
  • ELA 1965
  • TLSA 2013
  • Country
  • ELA United States
  • TLSA United Kingdom
  • Employees
  • ELA N/A
  • TLSA N/A
  • Industry
  • ELA Consumer Specialties
  • TLSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ELA Consumer Discretionary
  • TLSA Health Care
  • Exchange
  • ELA Nasdaq
  • TLSA Nasdaq
  • Market Cap
  • ELA 156.2M
  • TLSA 187.0M
  • IPO Year
  • ELA N/A
  • TLSA 2000
  • Fundamental
  • Price
  • ELA $6.04
  • TLSA $1.45
  • Analyst Decision
  • ELA Strong Buy
  • TLSA
  • Analyst Count
  • ELA 1
  • TLSA 0
  • Target Price
  • ELA $9.00
  • TLSA N/A
  • AVG Volume (30 Days)
  • ELA 66.1K
  • TLSA 246.7K
  • Earning Date
  • ELA 08-06-2025
  • TLSA 07-22-2025
  • Dividend Yield
  • ELA N/A
  • TLSA N/A
  • EPS Growth
  • ELA 15.15
  • TLSA N/A
  • EPS
  • ELA 0.28
  • TLSA N/A
  • Revenue
  • ELA $188,774,278.00
  • TLSA N/A
  • Revenue This Year
  • ELA $7.61
  • TLSA N/A
  • Revenue Next Year
  • ELA $6.27
  • TLSA N/A
  • P/E Ratio
  • ELA $22.80
  • TLSA N/A
  • Revenue Growth
  • ELA 14.19
  • TLSA N/A
  • 52 Week Low
  • ELA $4.20
  • TLSA $0.63
  • 52 Week High
  • ELA $7.88
  • TLSA $1.91
  • Technical
  • Relative Strength Index (RSI)
  • ELA 50.27
  • TLSA 48.43
  • Support Level
  • ELA $5.97
  • TLSA $1.43
  • Resistance Level
  • ELA $6.35
  • TLSA $1.81
  • Average True Range (ATR)
  • ELA 0.25
  • TLSA 0.09
  • MACD
  • ELA 0.04
  • TLSA -0.02
  • Stochastic Oscillator
  • ELA 53.73
  • TLSA 18.53

About ELA Envela Corporation

Envela Corp is a provider of recycling and re-commerce services at the forefront of the circular economy. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: